Minimal residual disease detection in myeloma: no more molecular remissions?
Rawstron
Andy C
AC
HMDS, Algernon Firth Building, Leeds Teaching Hospital, Leeds, UK. andy.rawstron@hmds.org.uk
D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000235:genetics; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction / Q000379:methods; D012074:Remission Induction